Alison Sehgal, MD, MS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia (NCT02631252) | Alison Sehgal, MD, MS | 2016-08-18 |
Track Alison Sehgal, MD, MS automatically
Every clearance here is in the API, with alerts when new ones post.